본문 바로가기
bar_progress

Text Size

Close

Possibility of Moderna Vaccine Booster Shot Approval!! Which All-Time Core Stocks Will Benefit??

US FDA Actively Reviewing Approval for Moderna COVID-19 Vaccine Booster Shot!!


Moderna Booster Shot Shows Enhanced Immune Efficacy Against Delta Variant, FDA Clinical Data Submitted!!


Following Nanocovax, even Moderna is a significantly undervalued COVID vaccine beneficiary stock with a potential increase of 1000%! Check it before it's too late!


Check out the TOP 3 mRNA-related stocks that will benefit from the COVID-19 vaccine boom and click TOP 1 for information and response!


●TOP 3● Ilyang Pharmaceutical (094820): Pharmaceutical company with facilities capable of producing finished mRNA products. Annual production capacity of 1.4 billion doses, receiving overseas love calls.


●TOP 2● ST Pharm (189860): News of discovering a delta variant-targeted mRNA vaccine and participating in a consortium developing next-generation mRNA vaccine platforms.


●TOP 1● (***0**) : Ultra-high growth imminent stock, limited to the first 10 people ★Free Disclosure★ ▶Click◀


★Bonus Hidden Stock★ This is it!! Also limited to the first 10 people ▶Check Stock◀


Only a few days left!! It’s going up right away!! Hurry and grab it before it’s too late!!


Possibility of Moderna Vaccine Booster Shot Approval!! Which All-Time Core Stocks Will Benefit??

Cumulative Profit Achievement Event! 3 stocks that achieved 상승 within 2 days spotted! Free disclosure for the first 50 people!! ▶Click!◀


[Profit Status by Stock]


Doosan Heavy Industries +142% profit!


KEPCO Engineering & Construction +151% profit!


Bioneer +169% profit!


Mad Factor +308% profit!


ATECTN 130% profit!


Sang-A Frontec +121% profit!


[Today's Stocks of Interest]: Namseong / Sama Aluminum / Next Science / Daewoo Electronic Materials / Cosmo Chemical


※ This content is unrelated to the editorial direction of Asia Economy, and all responsibility lies with the information provider.


© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Special Coverage


Join us on social!

Top